Search results
Results from the WOW.Com Content Network
Dwarfism is a condition of people and animals marked by unusually small size or short stature. [1] In humans, it is sometimes defined as an adult height of less than 147 centimetres (4 ft 10 in), regardless of sex; the average adult height among people with dwarfism is 120 centimetres (4 ft).
Achondroplasia is a genetic disorder with an autosomal dominant pattern of inheritance whose primary feature is dwarfism. [3] It is the most common cause of dwarfism [4] and affects about 1 in 27,500 people. [3] In those with the condition, the arms and legs are short, while the torso is typically of normal length. [3]
Achondroplasia in children is the most common form of dwarfism; it accounts for about 70% of all cases of dwarfism. [1] Achondroplasia falls into the category of “disproportionate dwarfism”. It is linked to a mutation in the fibroblast growth factor receptor-3.
It is thought that chondrodystrophy [2] is caused by an autosomal, recessive allele.To avoid a potential "lethal dose", both parents can be genetically tested.If a child is conceived with another carrier the outcome may be lethal, or the child may suffer from chondrodystrophy or dwarfism. [3]
Shortened stature can result from growth hormone deficiency, starvation, portal systemic shunts, renal disease, hypothyroidism diabetes mellitus and other conditions. Any of these conditions can be established in a population through genetic engineering, selective breeding, or insular dwarfism, or some combination of the above.
Dwarfism, low-birth-weight type with unresponsiveness to growth hormone is a very rare genetic disorder which is characterized by developmental delays, intellectual disabilities, and other anomalies. Only 2 cases have been described in medical literature.
Most little people have a normal life expectancy, but many suffer from orthopedic complications, which can often be treated with surgery. “Little People, Big World” airs Tuesdays at 9/8 ...
Laron syndrome (LS), also known as growth hormone insensitivity or growth hormone receptor deficiency (GHRD), is an autosomal recessive disorder characterized by a lack of insulin-like growth factor 1 (IGF-1; somatomedin-C) production in response to growth hormone (GH; hGH; somatotropin). [6]